Psychemedics Corporation - PMD Net Assets per Single Share

Graphic logo of Psychemedics (PMD)

The book value per share of Psychemedics demonstrates capital resilience backed by long-term B2B personnel screening agreements. The 0.92 mark captures this metric, confirming the current impact of implementing unique hair tests. However, the legalization of certain substances and the rise of rapid diagnostics create risks of declining demand, which could negatively affect the issuer's final revenue.

PMD: Psychemedics Corp. Net Asset Value per Share 07/04/2022 - 12/21/2024

psychemedics.com - analytical breakdowns and key metrics (PMD)

- price and consensus price forecast:
Stock Price Psychemedics Corp|PMD - Broker Consensus Forecast
- market capitalization data:
Market Value Psychemedics Corporation|PMD - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Psychemedics|PMD - Total Stockholders' Equity|Market Capitalization to Book Value Ratio psychemedics.com|PMD - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Psychemedics|PMD - Long-Term Debt to Capital|Short-Term Debt to Equity Psychemedics Corporation|PMD - Company Aggregate Debt|Debts to Book Capitalization Psychemedics Corporation
Analysis of all company metrics:Psychemedics Corp (PMD)
Manufactured products of Psychemedics Corporation

Book value per share reflects the residual capital of the business net of all liabilities, demonstrating the actual rate of fundamental asset accumulation per share. The trend in book value per share isolates the operational resilience of Psychemedics (PMD) from market noise, confirming the company's ability to convert B2B revenues from high-precision laboratory examinations into long-term financial reliability for investors.

Competitor analysis for Psychemedics

Agilent Tech (A) - Book Value per Share|DGX: Equity per Share|ILMN (Illumina, Inc.) - Net Assets per Single Share|exactsciences.com (EXAS) - Accounting Value per Share|Book Value per Share RVTY (Revvity)|Net Asset Value per Share Bio-Rad Laboratories, Inc.|Book Value per Share Anbio Tech NNNN|Equity per Share Nordion (SHC)|Book Value per Share QDEL (QuidelOrtho)|opko.com - Book Value per Share|CareDx, Inc (CDNA) - Net Assets per Single Share|MRVI - Equity per Share|FLGT: Book Value per Share|LAB (Standard BioTools Corp) - Book Value per Share|Net Assets per Single Share Cytek Biosciences, Inc.|Net Assets per Single Share orasure.com (OSUR)|Exagen Inc. - Accounting Value per Share|Net Asset Value per Share MDXH (MDxHealth S.A.)|Net Assets per Single Share LUCD|Net Assets per Share Prenetics Global Limited PRE|Book Value per Share IMDX (Insight Molecular)|TRIB: Net Assets per Share|ProPhase Labs - Net Assets per Single Share|AIMD (Ainos Inc) - Net Assets per Share|Net Assets per Single Share Co-Diagnostics Corp CODX|Share Book Value HSCS|BMRA (Biomerica, Inc.) - Net Assets per Single Share|Net Assets per Share cardiodiagnosticsinc.com CDIO|VRAX: Accounting Value per Share|Net Asset Value per Share Bluejay Diagnostics Inc BJDX|AWH: Book Value per Share|AXDX - Accounting Value per Share|Book Value per Share centogene.com CNTG|Enzo Biochem (ENZ) - Accounting Value of a Share|Book Value per Share FRES (Fresh2 Group Ltd)|Net Asset Value per Share GENE|Net Assets per Single Share ME (23andMe Inc.)